215 related articles for article (PubMed ID: 35956154)
1. Propranolol: A "Pick and Roll" Team Player in Benign Tumors and Cancer Therapies.
Albiñana V; Gallardo-Vara E; Casado-Vela J; Recio-Poveda L; Botella LM; Cuesta AM
J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956154
[TBL] [Abstract][Full Text] [Related]
2. The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases.
Cuesta AM; Gallardo-Vara E; Casado-Vela J; Recio-Poveda L; Botella LM; Albiñana V
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457036
[TBL] [Abstract][Full Text] [Related]
3. Propranolol represses infantile hemangioma cell growth through the β2-adrenergic receptor in a HIF-1α-dependent manner.
Li P; Guo Z; Gao Y; Pan W
Oncol Rep; 2015 Jun; 33(6):3099-107. PubMed ID: 25872592
[TBL] [Abstract][Full Text] [Related]
4. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.
Munabi NC; England RW; Edwards AK; Kitajewski AA; Tan QK; Weinstein A; Kung JE; Wilcox M; Kitajewski JK; Shawber CJ; Wu JK
Stem Cells Transl Med; 2016 Jan; 5(1):45-55. PubMed ID: 26574555
[TBL] [Abstract][Full Text] [Related]
5. Interventions for infantile haemangiomas of the skin.
Novoa M; Baselga E; Beltran S; Giraldo L; Shahbaz A; Pardo-Hernandez H; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD006545. PubMed ID: 29667726
[TBL] [Abstract][Full Text] [Related]
6. Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade.
Moisan F; Oucherif S; Kaulanjan-Checkmodine P; Prey S; Rousseau B; Bonneu M; Claverol S; Gontier E; Lacomme S; Dousset L; Couffinhal T; Toutain J; Loot M; Cario-André M; Jullié ML; Léauté-Labrèze C; Taieb A; Rezvani HR
Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33558238
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of propranolol action in infantile hemangioma.
Kum JJ; Khan ZA
Dermatoendocrinol; 2014; 6(1):e979699. PubMed ID: 26413184
[TBL] [Abstract][Full Text] [Related]
8. Role of Thrombospondin-1 and Nuclear Factor-κB Signaling Pathways in Antiangiogenesis of Infantile Hemangioma.
Xu W; Li S; Yu F; Zhang Y; Yang X; An W; Wang W; Sun C
Plast Reconstr Surg; 2018 Sep; 142(3):310e-321e. PubMed ID: 30148773
[TBL] [Abstract][Full Text] [Related]
9. Nadolol for the treatment of infantile hemangioma.
Villalba-Moreno AM; Cotrina-Luque J; Del Vayo-Benito CA; Flores-Moreno S; Bautista-Paloma FJ
Am J Health Syst Pharm; 2015 Jan; 72(1):44-6. PubMed ID: 25511837
[TBL] [Abstract][Full Text] [Related]
10. Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel-Lindau Disease.
Albiñana V; Gallardo-Vara E; de Rojas-P I; Recio-Poveda L; Aguado T; Canto-Cano A; Aguirre DT; Serra MM; González-Peramato P; Martínez-Piñeiro L; Cuesta AM; Botella LM
J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32854260
[TBL] [Abstract][Full Text] [Related]
11. Infantile Hemangiomas: Pathogenesis and Review of Propranolol Use.
Laken PA
Adv Neonatal Care; 2016 Apr; 16(2):135-42. PubMed ID: 26945282
[TBL] [Abstract][Full Text] [Related]
12. Propranolol Therapy in Infantile Hemangioma: It Is Not Just About the Beta.
Lee JC; Modiri O; England RW; Shawber CJ; Wu JK
Plast Reconstr Surg; 2021 Apr; 147(4):875-885. PubMed ID: 33776033
[TBL] [Abstract][Full Text] [Related]
13. Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.
Pasquier E; André N; Street J; Chougule A; Rekhi B; Ghosh J; Philip DSJ; Meurer M; MacKenzie KL; Kavallaris M; Banavali SD
EBioMedicine; 2016 Apr; 6():87-95. PubMed ID: 27211551
[TBL] [Abstract][Full Text] [Related]
14. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol.
Zhu L; Xie J; Liu Z; Huang Z; Huang M; Yin H; Qi W; Yang Z; Zhou T; Gao G; Zhang J; Yang X
Cancer Sci; 2018 Jun; 109(6):1981-1994. PubMed ID: 29664206
[TBL] [Abstract][Full Text] [Related]
15. ADRB2-Targeting Therapies for Prostate Cancer.
Kulik G
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30871232
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma.
Wolter JK; Wolter NE; Blanch A; Partridge T; Cheng L; Morgenstern DA; Podkowa M; Kaplan DR; Irwin MS
Oncotarget; 2014 Jan; 5(1):161-72. PubMed ID: 24389287
[TBL] [Abstract][Full Text] [Related]
17. Initial experience with a multidisciplinary strategy for initiation of propranolol therapy for infantile hemangiomas.
Cushing SL; Boucek RJ; Manning SC; Sidbury R; Perkins JA
Otolaryngol Head Neck Surg; 2011 Jan; 144(1):78-84. PubMed ID: 21493392
[TBL] [Abstract][Full Text] [Related]
18. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
Albiñana V; Villar Gómez de Las Heras K; Serrano-Heras G; Segura T; Perona-Moratalla AB; Mota-Pérez M; de Campos JM; Botella LM
Orphanet J Rare Dis; 2015 Sep; 10():118. PubMed ID: 26394686
[TBL] [Abstract][Full Text] [Related]
19. Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.
Filippi L; Dal Monte M; Casini G; Daniotti M; Sereni F; Bagnoli P
Med Res Rev; 2015 May; 35(3):619-52. PubMed ID: 25523517
[TBL] [Abstract][Full Text] [Related]
20. A transcription factor is the target of propranolol treatment in infantile hemangioma.
Schrenk S; Boscolo E
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 35104803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
